Oncolytics Biotech Mutual Funds

Health Care & Life Sciences » Biotechnology | Oncolytics Biotech Inc.

Oncolytics Biotech Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

CI Canadian Small/Mid Cap Fund

54,895

0.37%

54,895

0.06%

06/30/2017

View Profile

Address	1167 Kensington Crescent NW Calgary Alberta T2N 1X7 Canada
Employees	-
Website	http://www.oncolyticsbiotech.com
Updated	07/08/2019
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus called REOLYSIN. The company was founded by Matthew C.